Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

GM CEO Mary Barra departs the White House on Sept. 5. Photo: Reuters/David Shepardson

GM CEO Mary Barra paid a visit to the Oval Office Thursday, no doubt an awkward meeting after the pounding the automaker has taken from President Trump on Twitter lately.

The big picture: GM is facing intense pressure from the White House to bring jobs back from China and Mexico after announcing plans to idle 4 U.S. factories in important swing states.

  • But with plenty to talk about — jobs, trade, fuel economy — Barra called it a "productive and valuable" session and the White House didn't disagree.

What's happening: The United Auto Workers union, steaming about the intended plant closings, has selected GM to set a new pattern labor agreement for the industry.

  • Union members have authorized a national strike if a deal isn't reached by the Sept. 14 deadline.

Between the lines: The 4 GM factories have been designated as "unallocated" — meaning GM has no products assigned to those plants in the future. (A fifth is unallocated in Canada, where workers belong to a different union.)

  • The semantics matter: Under the existing labor contract, GM can't close, idle, sell off or consolidate plants, except in the case of a sudden market downturn or an act of God. Hence, the odd term "unallocated."
  • The UAW sued GM for violating the agreement, but the issue is likely to be resolved at the bargaining table long before it is heard in court.
  • Although 3 of the 4 factories have already stopped production, none of the factories can be shuttered for good without the union's sign-off.
  • "These plants are absolutely bargaining chips and the union is not going to give up on allocating those plants without getting something in return," says Kristin Dziczek of the Center for Automotive Research.

What to watch: As in previous negotiations, GM likely has plans to "save" hundreds of jobs in exchange for worker concessions on health care or other benefits. Among the possibilities:

  • GM plans to introduce 20 new electric vehicles by 2023, mostly for the Chinese market, but Barra has told Axios that at least some will be built in the U.S.
  • GM could also transfer some production from Mexico, where it currently builds pickups, SUVs, engines and transmissions.
  • But U.S. autoworkers earn roughly $30 per hour vs. $3 for their Mexican counterparts, Dziczek notes.
  • About 2,000 of 2,800 affected union workers have already accepted transfers to other GM plants — receiving $5,000–$30,000 incentive pay — but many could return to their home plants if production is restarted.

The bottom line: The drama will increase between now and the Sept. 14 contract deadline, but look for hundreds of U.S. manufacturing jobs to be created or retained — an outcome likely to please Trump.

Go deeper: The American car is becoming obsolete

Go deeper

Ben Geman, author of Generate
47 mins ago - Energy & Environment

Democrats' clean power outlook is very muddy

Illustration: Annelise Capossela/Axios

Here are two big questions as a key Democratic proposal to slash emissions from power generation flounders: how much its demise would sap climate protections, and what might replace it.

Catch up fast: New financial carrots and sticks for utilities to deploy zero-carbon power — the Clean Electricity Performance Program (CEPP) — look unlikely to stay in Democrats' big social spending and climate bill.

Colin Powell dies from COVID complications at 84

Photo: Paul Morigi/Getty Images for Capital Concerts

Colin Powell, the first Black U.S. secretary of state, died of complications from COVID-19, his family announced Monday. He was 84.

Driving the news: The Powell family said in a statement that he was fully vaccinated. "We want to thank the medical staff at Walter Reed National Medical Center for their caring treatment."

3 hours ago - Health

This arthritis drug cost $198 in 2008. Now it's more than $10,000

Illustration: Aïda Amer/Axios

In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin, had a price tag of $198. As of Oct. 1, the price of that same box was 52 times higher, totaling $10,350.

Why it matters: As federal lawmakers continue to waver on drug price reforms, Indocin is another example of how nothing prevents drug companies from hiking prices at will and selling them within a broken supply chain.